Incidence and Survival Among Young Women With Stage I-III Breast Cancer: SEER 2000-2015.

Alexandra Thomas Anthony Rhoads Elizabeth PinkertonMary C SchroederKristin M ConwayWilliam G HundleyLacey R McNallyJacob OlesonCharles F LynchPaul A Romitti

Published in: JNCI cancer spectrum (2019)

HR+ breast cancer is increasing in incidence among premenopausal women, and HR+ high-grade cancer was associated with reduced survival among women aged 20-29 years. Our findings can help guide further evaluation of preventive, diagnostic, and therapeutic strategies for breast cancer among premenopausal women.

Keyphrases

breast cancer risk
polycystic ovary syndrome
high grade
pregnancy outcomes
risk factors
postmenopausal women
type diabetes
papillary thyroid
squamous cell carcinoma
insulin resistance
metabolic syndrome
young adults
pregnant women
adipose tissue
squamous cell